Brian N. Kelly, PhD, DABCC, FADLM, After earning undergraduate degrees in Biochemistry and Molecular, Cellular, and Developmental Biology from the University of Colorado I pursued a PhD in Biochemistry from the University of Utah. Subsequently, I completed a 3-year post-doctoral fellowship in Clinical Chemistry and Laboratory Medicine at the University of Virginia. As a clinical toxicology specialist with ARUP, I review test results to investigate whether a patient is compliant with prescribed medications and not using illicit or non-prescribed medications. At ARUP, I also have the pleasure of teaching residents and fellows in Pathology. In my independent consulting business, I assist small to mid-size clinical laboratories in the implementation of liquid-chromatography mass-spectrometry based analysis of biological specimens, among other methods, as well as providing ongoing regulatory oversight.
Education History
Research Fellow |
Sports Medicine Research and Testing Laboratory |
Research Fellow |
---|---|---|
University of Virginia |
Clinical Research Fellow | |
Doctoral Training |
University of Utah |
PhD |
University of Colorado |
BA | |
Undergraduate |
University of Colorado |
BA |
Selected Publications
Journal Article
- Boyd JM, Kelly BN, McMillin GA (2024). Prevalence of Gabapentinoid and Opioid Copositives in a Reference Laboratory Patient Population. J Appl Lab Med, 9(4), 861-863. (Read full article)
- Kelly BN (2023). UTI detection by PCR: Improving patient outcomes. J Mass Spectrom Adv Clin Lab, 28, 60-62. (Read full article)
- McMillin GA, Johnson-Davis KL, Kelly BN, Scott B, Yang YK (2020). Impact of the Opioid Epidemic on Drug Testing. Ther Drug Monit, 43(1), 14-24. (Read full article)
- Snozek CLH, Baskin LB, Boyd JM, Kelly BN, Krasowski MD, Sadrzadeh SMH, Tacker DH (2020). How Can Routine Clinical Laboratories Keep Up with the Opioid Crisis? Clin Chem, 67(2), 338-344. (Read full article)
- Yang YK, Johnson-Davis KL, Kelly BN, McMillin GA (2020). Demand for Interpretation of a Urine Drug Testing Panel Reflects the Changing Landscape of Clinical Needs; Opportunities for the Laboratory to Provide Added Clinical Value. J Appl Lab Med, 5(5), 858-868. (Read full article)
- Kelly BN, Haverstick DM, Lee JK, Thorner MO, Vance ML, Xin W, Bruns DE (2014). Circulating microRNA as a biomarker of human growth hormone administration to patients. Drug Test Anal, 6(3), 234-8. (Read full article)
- Kelly BN, Madsen M, Sharpe K, Nair V, Eichner D (2013). A population study of urine glycerol concentrations in elite athletes competing in North America. Drug Test Anal, 5(11-12), 890-5. (Read full article)
- Kelly BN, Haverstick DM, Vance ML, Thorner MO, Bruns DE (2012). Quantification of growth hormone mRNA in blood. Clin Chim Acta, 414, 206-10. (Read full article)
- Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, Stout CD, Sundquist WI, Hill CP, Yeager M (2009). X-ray structures of the hexameric building block of the HIV capsid. Cell, 137(7), 1282-92. (Read full article)
- Kelly BN, Kyere S, Kinde I, Tang C, Howard BR, Robinson H, Sundquist WI, Summers MF, Hill CP (2007). Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. J Mol Biol, 373(2), 355-66. (Read full article)
- Kelly BN, Howard BR, Wang H, Robinson H, Sundquist WI, Hill CP (2006). Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1-278) and CA(N)(133-278). Biochemistry, 45(38), 11257-66. (Read full article)
- Sundquist WI, Schubert HL, Kelly BN, Hill GC, Holton JM, Hill CP (2004). Ubiquitin recognition by the human TSG101 protein. Mol Cell, 13(6), 783-9. (Read full article)
Commentary
- Brian N Kelly, PhD (Fall 2017). Sports Drug Testing Update.
Case Report
- Kelly, BN, Silverman, LM, Bruns, DE (2013). Unexpected Serum Protein Electrophoresis Results: Finding the lost monoclonal protein.
Letter
- Kelly BN, Haverstick DM, Bruns DE (2012). Interference in a glucose dehydrogenase-based glucose meter revisited. [Letter to the editor]. Clin Chim Acta, 413(7-8), 829-30. (Read full article)
- Kelly BN, Haverstick DM, Bruns DE (2010). Interference in a glucose dehydrogenase-based glucose meter. [Letter to the editor]. Clin Chem, 56(6), 1038-40. (Read full article)
Video/Film/CD/Web/Podcast
- Brian N Kelly (2009). One Cyclist’s Experience [Web]. Anti-Doping Research Web Site.
Patent
- Bruns DE, Haverstick DM, Kelly B (2019). Compositions and Methods for Detecting Aberrant Regulation, Expression, and Levels of hGH. U.S. Patent No. US 14/035,422. Washington, D.C.:U.S. Patent and Trademark Office.